Page 50 - Read Online

Page 8 of 11 Chávez-Castillo et al. Vessel Plus 2018;2:6 I http://dx.doi.org/10.20517/2574-1209.2018.02

3. Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. Eur Heart J 2014;35:1365-72.
4. Colquhoun DM, Bunker SJ, Clarke DM, Glozier N, Hare DL, Hickie IB, Tatoulis J, Thompson DR, Tofler GH, Wilson A, Branagan
MG. Screening, referral and treatment for depression in patients with coronary heart disease. Med J Aust 2013;198:483-4.
5. World Health Organization. Cardiovascular diseases. Media centre fact sheet. Updated May 2017. Available from: http://www.who.int/
mediacentre/factsheets/fs317/en/ [Last accessed on 10 Apr 2018]
6. Forman D, Bulwer BE. Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. Curr Treat Options
Cardiovasc Med 2006;8:47-57.
7. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mec 2009;2:231-7.
8. Olvera RL, Williamson DE, Fisher-Hoch SP, Vatcheva KP, McCormick JB. Depression, obesity, and metabolic syndrome: prevalence
and risks of comorbidity in a population-based representative sample of Mexican Americans. J Clin Psychiatry 2015;76:e1300-5.
9. Kahl KG, Schweiger U, Correll C, Müller C, Busch ML, Bauer M, Schwarz P. Depression, anxiety disorders, and metabolic syndrome
in a population at risk for type 2 diabetes mellitus. Brain Behav 2015;5:e00306.
10. McIntyre RS, Park KY, Law CW, Sultan F, Adams A, Lourenco MT, Lo AK, Soczynska JK, Woldeyohannes H, Alsuwaidan M, Yoon J,
Kennedy SH. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical
implications. CNS Drugs 2010;24:741-53.
11. Chokka P, Tancer M, Yeragani VK. Metabolic syndrome: relevance to antidepressant treatment. J Psychiatry Neurosci 2006;31:414.
12. Mitchell AJ, Delaffon V, Vancampfort D, Correll CU, De Hert M. Guideline concordant monitoring of metabolic risk in people treated
with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2012;42:125-47.
13. Riordan HJ, Antonini P, Murphy MF. Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors,
monitoring, and healthcare implications. Am Health Drug Benefits 2011;4:292-302.
14. Noordam R, Aarts N, Verhamme KM, Sturkenboom MC, Stricker BH, Visser LE. Prescription and indication trends of antidepressant
drugs in the Netherlands between 1996 and 2012: a dynamic population-based study. Eur J Clin Pharmacol 2015;71:369-75.
15. Tripathi A, Avasthi A, Desousa A, Bhagabati D, Shah N, Kallivayalil RA, Grover S, Trivedi JK, Shinfuku N. Prescription pattern of
antidepressants in five tertiary care psychiatric centres of India. Indian J Med Res 2016;143:507-13.
16. Santarsieri D, Schwartz TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context 2015;4:212290.
17. Chittaranjan A, Chethan K, Sandarsh S. Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease
and heart failure. Int Clin Psychopharmacol 2013;28:145-55.
18. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 2011;75:2739-48.
19. Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M. So depression
is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200.
20. Bica T, Castelló R, Toussaint LL, Montesó-Curto P. Depression as a risk factor of organic diseases: an international integrative review. J
Nurs Scholarsh 2017;49:389-99.
21. Chirinos DA, Murdock KW, LeRoy AS, Fagundes C. Depressive symptom profiles, cardio-metabolic risk and inflammation: results
from the MIDUS study. Psychoneuroendocrinology 2017;82:17-25.
22. Mathews MJ, Mathews EH, Liebenberg L. The mechanisms by which antidepressants may reduce coronary heart disease risk. BMC
Cardiovasc Disord 2015;15:82.
23. Maes M, Berk M, Goehler L, Song C, Anderson G, Gałecki P, Leonard B. Depression and sickness behavior are Janus-faced responses
to shared inflammatory pathways. BMC Med 2012;10:66.
24. Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM.
Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline
‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology 2013;38:377-85.
25. Taler M, Gil-Ad I, Lomnitski L, Korov I, Baharav E, Bar M, Zolokov A, Weizman A. Immunomodulatory effect of selective serotonin
reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol 2007;17:774-80.
26. Serebruany VL, Gurbel PA, O’Connor CM. Platelet inhibition by sertraline and n-desmethylsertraline: a possible missing link between
depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001;43:453-61.
27. Kubera M, Maes M, Kenis G, Kim Y, Lasoń W. Effects of serotonin and serotonergic agonists and antagonists on the production of
tumor necrosis factor α and interleukin-6. Psychiatry Res 2005;134:251-8.
28. Young MR, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology
1995;84:148-52.
29. Hellstrands K, Hermodsson S. Serotonergic 5-HT1a receptors regulate a cell contact-mediated interaction between natural killer cells
and monocytes. Scand J Immunol 1993;37:7-18.
30. Nieuwland R, Berckmans RJ, McGregor S, Böing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. Cellular origin and procoagulant
properties of microparticles in meningococcal sepsis. Blood 2000;95:930-5.
31. Shajib M, Khan W. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf)
2014;213:561-74.
32. Rudd ML, Nicolas AN, Brown BL, Fischer-Stenger K, Stewart JK. Peritoneal macrophages express the serotonin transporter. J
Neuroimmunol 2005;159:113-8.
33. de las Casas-Engel M, Domínguez-Soto A, Sierra-Filardi E, Bragado R, Nieto C, Puig-Kroger A, Samaniego R, Loza M, Corcuera MT,
Gómez-Aguado F, Bustos M, Sánchez-Mateos P, Corbí AL. Serotonin skews human macrophage polarization through HTR2B and
HTR7. J Immunol 2013;190:2301-10.